Page last updated: 2024-11-06

climazolam

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

climazolam: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68790
CHEMBL ID2104070
SCHEMBL ID1311586
MeSH IDM0107885

Synonyms (20)

Synonym
climazolam
59467-77-5
D07714
climazolam (inn)
climasol [veterinary] (tn)
8-chloro-6-(2-chlorophenyl)-1-methyl-4h-imidazo[1,5-a][1,4]benzodiazepine
SCHEMBL1311586
CHEMBL2104070
climasol
4h-imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-methyl-
climazolamum [latin]
unii-o9kzb9hg1y
8-chloro-6-(o-chlorophenyl)-1-methyl-4h-imidazo(1,5-a)(1,4)benzodiazepine
climazolamum
o9kzb9hg1y ,
climazolam [inn]
8-chloro-6-(o-chlorophenyl)-1-methyl-4h-imidazo(1,5-.alpha.)(1,4)benzodiazepine
CHCISLOJADQUNQ-UHFFFAOYSA-N
DTXSID30208173
Q5133651

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The dosage based on experimental studies."( [Clinical investigations of an i.m. combination anesthesia with fentanylclimazolam/xylazine and postoperative i.v. antagonism with naloxone/sarmazenil/yohimbine in guinea pigs].
Brill, T; Erhardt, W; Henke, J; Lendl, C; Matis, U; Otto, K; Roberts, U, 1996
)
0.53
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (45.45)18.7374
1990's4 (36.36)18.2507
2000's2 (18.18)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.94 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]